The FDA has granted accelerated approval to Otsuka’s Voyxact for adults with primary IgAN at risk of disease progression, ...
This designation highlights the significance of SkinTE, which is one of the few regenerative biologics pursuing BLA approval in a chronic wound indication. Given the critical context that there have ...
As previously announced, PainReform and LayerBio plan to advance OcuRing-K through its next stage of clinical development in the United States, where approval could unlock a high-volume reimbursable ...
Children with avoidant/restrictive food intake were significantly more likely than control individuals to have developmental ...
A new study highlights how important uninterrupted sleep is to recovery after a traumatic brain injury, finding that ...
Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12 weeks observed after a ...
Investing.com -- Jasper Therapeutics Inc (NASDAQ:JSPR) stock surged 17.4% in premarket trading Tuesday after the clinical-stage biotech company reported positive preliminary data from its ETESIAN ...
Clearmind Medicine (CMND) announced another key milestone in its Phase I/IIa clinical trial for the treatment of Alcohol Use Disorder: the first ...
Biopharma company Reig Jofre has consolidated its stake in Leanbio, a fellow Barcelona-based firm focused on the design, ...
Zacks Investment Research on MSN
MIRM Enrolls First Patient in Phase II Fragile X Syndrome Study
Mirum Pharmaceuticals MIRM announced that it has enrolled the first patient in the phase II BLOOM study evaluating its newly ...
The shingles vaccine not only offers protection against the painful viral infection, a new study suggests that the two-dose ...
Ruiz, an internationally recognized ophthalmologist and experienced drug development leader, has joined the company as Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback